Jianzhong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Jianzhong Wang has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Xingyuan Cao
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
15 shared publications Jicheng Qiu
Beijing Yuanda Xinghuo Pharmaceutical Technology Co, Beijing, China
8 shared publicationsSuxia Zhang
Department of Veterinary Pharmacology and Toxicology College of Veterinary Medicine China Agricultural University Beijing China
7 shared publications- Hongquan Li
Shanxi Agricultural University
6 shared publications - Huizhen Yang
Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China
6 shared publications - Jia Zhong
Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China
6 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (11) , 1181
Establishment and Characterization of a Piglet Model for Pulmonary Heat-Induced Cough and Asthma Syndrome
Porcine lung-heat cough and asthma syndrome is mainly caused by mixed infections of viruses, bacteria and other pathogens. It is characterized by disturbed lung movement and accumulated heat in the lung, with typical clinical signs including fever, cough, purulent nasal discharge and dyspnea. To construct an exploratory model mimicking its clinical features, twelve healthy piglets were randomly divided into a control group (mock-infected) and three Influenza A virus subtype (H1N1)-infected groups (high-dose, medium-dose and low-dose virus challenge). Piglets in the three challenged groups were intranasally inoculated with H1N1 influenza virus at high, medium, or low doses, while the control group received mock inoculation with DMEM. Clinical symptoms were monitored throughout the experiment. On day 8 post infection(dpi), samples of the heart, liver, spleen, lung, kidney, trachea and various intestinal segments were collected for histopathological observation and viral load detection. We conducted disease target enrichment analysis to screen core targets in lung tissues after H1N1 infection, and further verified the results via Western blot. H1N1 infection induced typical symptoms in piglets, such as fever, purulent nasal discharge, cough, dyspnea, decreased feed intake, reduced average daily gain, elevated feed conversion ratio and listlessness. Obvious pathological lesions were found in the trachea, lung, liver and kidney, and H1N1 virus was detected in tracheal and lung tissues. Enrichment analysis revealed that the Phosphatidylinositol 3-kinase–protein kinase B (PI3K–Akt) signaling pathway participates in lung injury progression induced by H1N1 infection. Further molecular detection indicated that H1N1 infection was associated with changes in PI3K–Akt signaling while upregulating Class III PI3K, simultaneously accompanied by alterations in autophagy- and apoptosis-related markers and potentially associated with pulmonary injury. The established piglet model is largely consistent with the diagnostic criteria for porcine lung-heat cough and asthma pattern stated in the Technical Guidelines for Clinical Research of Traditional Chinese Veterinary Medicine for Porcine Lung-Heat Cough and Asthma Syndrome issued by the Ministry of Agriculture and Rural Affairs of China. In summary, this study established an exploratory model of H1N1-induced lung-heat cough and asthma in piglets. The observed phenotypic and molecular characteristics provide preliminary evidence for subsequent investigations into the disease mechanism.
- 31 October 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (11) , 1181
Open AccessEstablishment and Characterization of a Piglet Model for Pulmonary Heat-Induced Cough and Asthma Syndrome
Porcine lung-heat cough and asthma syndrome is mainly caused by mixed infections of viruses, bacteria and other pathogens. It is characterized by disturbed lung movement and accumulated heat in the lung, with typical clinical signs including fever, cough, purulent nasal discharge and dyspnea. To construct an exploratory model mimicking its clinical features, twelve healthy piglets were randomly divided into a control group (mock-infected) and three Influenza A virus subtype (H1N1)-infected groups (high-dose, medium-dose and low-dose virus challenge). Piglets in the three challenged groups were intranasally inoculated with H1N1 influenza virus at high, medium, or low doses, while the control group received mock inoculation with DMEM. Clinical symptoms were monitored throughout the experiment. On day 8 post infection(dpi), samples of the heart, liver, spleen, lung, kidney, trachea and various intestinal segments were collected for histopathological observation and viral load detection. We conducted disease target enrichment analysis to screen core targets in lung tissues after H1N1 infection, and further verified the results via Western blot. H1N1 infection induced typical symptoms in piglets, such as fever, purulent nasal discharge, cough, dyspnea, decreased feed intake, reduced average daily gain, elevated feed conversion ratio and listlessness. Obvious pathological lesions were found in the trachea, lung, liver and kidney, and H1N1 virus was detected in tracheal and lung tissues. Enrichment analysis revealed that the Phosphatidylinositol 3-kinase–protein kinase B (PI3K–Akt) signaling pathway participates in lung injury progression induced by H1N1 infection. Further molecular detection indicated that H1N1 infection was associated with changes in PI3K–Akt signaling while upregulating Class III PI3K, simultaneously accompanied by alterations in autophagy- and apoptosis-related markers and potentially associated with pulmonary injury. The established piglet model is largely consistent with the diagnostic criteria for porcine lung-heat cough and asthma pattern stated in the Technical Guidelines for Clinical Research of Traditional Chinese Veterinary Medicine for Porcine Lung-Heat Cough and Asthma Syndrome issued by the Ministry of Agriculture and Rural Affairs of China. In summary, this study established an exploratory model of H1N1-induced lung-heat cough and asthma in piglets. The observed phenotypic and molecular characteristics provide preliminary evidence for subsequent investigations into the disease mechanism.
- 26 August 2026
- Published by Wiley in Veterinary Record Case Reports
- Vol. 14 (4) , e70561
Venetoclax in combination with azacitidine induced remission in a cat with relapsed myelodysplastic syndrome following failure of azacitidine monotherapy
Summary: Myelodysplastic syndromes (MDS) are rare in cats, and relapse after azacitidine is difficult to manage. A 3‐year‐old, neutered, male British shorthair cat with MDS with refractory anaemia with excess blasts achieved three remissions on azacitidine (35 mg/m 2 subcutaneously for 3–4 days every 21 days), but relapsed with severe cytopenias and splenomegaly. Azacitidine re‐challenge failed, requiring four whole‐blood transfusions in 17 days. Salvage azacitidine (35 mg/m 2 subcutaneously for 5 days) plus venetoclax (360 mg/m 2 orally daily planned for 28 days) induced clinical remission, with notable improvements in appetite and activity, reduced transfusion dependence, and reduced splenomegaly, representing the first reported feline use of this combination. Toxicities were monitored with serial complete blood counts and Veterinary Cooperative Oncology Group's Common Terminology Criteria for Adverse Events grading. Dose‐limiting Grade 4 neutropenia and thrombocytopenia and severe gastrointestinal toxicity with fever occurred during Cycle 2, prompting venetoclax discontinuation and hospitalisation for intensive supportive care and antimicrobials. Survival was 168 days from venetoclax initiation, supporting B‐cell lymphoma 2 inhibition as salvage, while highlighting cautious dosing and frequent monitoring.
- 26 August 2026
- Published by Wiley in Veterinary Record Case Reports
- Vol. 14 (4) , e70561
Venetoclax in combination with azacitidine induced remission in a cat with relapsed myelodysplastic syndrome following failure of azacitidine monotherapy
Summary: Myelodysplastic syndromes (MDS) are rare in cats, and relapse after azacitidine is difficult to manage. A 3‐year‐old, neutered, male British shorthair cat with MDS with refractory anaemia with excess blasts achieved three remissions on azacitidine (35 mg/m 2 subcutaneously for 3–4 days every 21 days), but relapsed with severe cytopenias and splenomegaly. Azacitidine re‐challenge failed, requiring four whole‐blood transfusions in 17 days. Salvage azacitidine (35 mg/m 2 subcutaneously for 5 days) plus venetoclax (360 mg/m 2 orally daily planned for 28 days) induced clinical remission, with notable improvements in appetite and activity, reduced transfusion dependence, and reduced splenomegaly, representing the first reported feline use of this combination. Toxicities were monitored with serial complete blood counts and Veterinary Cooperative Oncology Group's Common Terminology Criteria for Adverse Events grading. Dose‐limiting Grade 4 neutropenia and thrombocytopenia and severe gastrointestinal toxicity with fever occurred during Cycle 2, prompting venetoclax discontinuation and hospitalisation for intensive supportive care and antimicrobials. Survival was 168 days from venetoclax initiation, supporting B‐cell lymphoma 2 inhibition as salvage, while highlighting cautious dosing and frequent monitoring.
- Open Access
- 22 July 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (7) , 719
Scutellarin Alleviates Zearalenone-Induced Injury in Porcine Ovarian Granulosa Cells Through WNT5A-Associated Regulation of Cell-Cycle-Related Proteins
Zearalenone is a common mycotoxin that impairs reproductive function, particularly by damaging ovarian granulosa cells. This study investigated the protective effect and underlying mechanism of scutellarin against zearalenone-induced injury in porcine ovarian granulosa cells. Cells were isolated and identified by follicle-stimulating hormone receptor immunofluorescence. Cell viability, cell-cycle distribution, and related molecular changes were evaluated using the MTT assay, flow cytometry, qRT-PCR, and Western blot. Scutellarin showed no obvious cytotoxicity within the tested range and attenuated the zearalenone-induced reduction in cell viability. Flow cytometry analysis demonstrated that scutellarin alleviated zearalenone-induced cell-cycle disturbance. At the molecular level, scutellarin upregulated the expression of cell-cycle-related factors, including CDK1, CDK2, CDK4, and PCNA, and increased the expression of Wnt/β-catenin signaling-related proteins, including WNT5A, β-catenin, c-MYC, and CCND1. WNT5A knockdown further indicated that scutellarin-mediated regulation of PCNA, CDK1, and CDK4 is WNT5A-dependent, whereas its effect on CDK2 may involve a WNT5A-independent mechanism. These findings indicate that scutellarin alleviates zearalenone-induced granulosa cell injury partly through WNT5A-associated modulation of cell-cycle-related proteins, providing mechanistic insights for its protective effects.
- 22 July 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (7) , 719
Open AccessScutellarin Alleviates Zearalenone-Induced Injury in Porcine Ovarian Granulosa Cells Through WNT5A-Associated Regulation of Cell-Cycle-Related Proteins
Zearalenone is a common mycotoxin that impairs reproductive function, particularly by damaging ovarian granulosa cells. This study investigated the protective effect and underlying mechanism of scutellarin against zearalenone-induced injury in porcine ovarian granulosa cells. Cells were isolated and identified by follicle-stimulating hormone receptor immunofluorescence. Cell viability, cell-cycle distribution, and related molecular changes were evaluated using the MTT assay, flow cytometry, qRT-PCR, and Western blot. Scutellarin showed no obvious cytotoxicity within the tested range and attenuated the zearalenone-induced reduction in cell viability. Flow cytometry analysis demonstrated that scutellarin alleviated zearalenone-induced cell-cycle disturbance. At the molecular level, scutellarin upregulated the expression of cell-cycle-related factors, including CDK1, CDK2, CDK4, and PCNA, and increased the expression of Wnt/β-catenin signaling-related proteins, including WNT5A, β-catenin, c-MYC, and CCND1. WNT5A knockdown further indicated that scutellarin-mediated regulation of PCNA, CDK1, and CDK4 is WNT5A-dependent, whereas its effect on CDK2 may involve a WNT5A-independent mechanism. These findings indicate that scutellarin alleviates zearalenone-induced granulosa cell injury partly through WNT5A-associated modulation of cell-cycle-related proteins, providing mechanistic insights for its protective effects.
- Open Access
- 3 July 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (7) , 652
Pharmacokinetic Profile of Matrine in Pigs Following Intravenous and Oral Administration
The search for effective alternatives or adjuncts to conventional anti-infective strategies in food animals has increased interest in plant-derived bioactive compounds. Matrine, a quinolizidine alkaloid derived from Sophora flavescens, has attracted considerable attention because of its broad bioactivities and potential veterinary relevance. Recent oral pharmacokinetic and intestinal-lumen PBPK studies in pigs have begun to emerge; however, currently available swine data remain largely confined to oral exposure-oriented experiments and do not permit direct route comparison or estimation of absolute oral bioavailability. In the present study, the plasma pharmacokinetics of matrine in pigs were evaluated after single-dose intravenous and oral administration. Twelve healthy piglets received matrine at 8 mg/kg body weight via either the intravenous or oral route, and plasma concentrations were quantified using a validated UPLC–MS/MS method. Pharmacokinetic parameters were estimated by non-compartmental analysis. Compared with intravenous administration, oral dosing produced lower observed exposure based on and a lower peak plasma concentration, with and values of 418.94 ± 75.52 h·ng/mL and 66.24 ± 8.44 ng/mL, respectively, versus 558.01 ± 59.57 h·ng/mL and 224.64 ± 20.94 ng/mL after intravenous administration. Oral administration was associated with a of 2.49 ± 0.02 h and a longer apparent terminal half-life and mean residence time than intravenous dosing. These findings provide pharmacokinetic evidence to support future route selection, dosing-regimen design, and PK/PD-based dose optimization of matrine in pigs.- 3 July 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (7) , 652
Open AccessPharmacokinetic Profile of Matrine in Pigs Following Intravenous and Oral Administration
The search for effective alternatives or adjuncts to conventional anti-infective strategies in food animals has increased interest in plant-derived bioactive compounds. Matrine, a quinolizidine alkaloid derived from Sophora flavescens, has attracted considerable attention because of its broad bioactivities and potential veterinary relevance. Recent oral pharmacokinetic and intestinal-lumen PBPK studies in pigs have begun to emerge; however, currently available swine data remain largely confined to oral exposure-oriented experiments and do not permit direct route comparison or estimation of absolute oral bioavailability. In the present study, the plasma pharmacokinetics of matrine in pigs were evaluated after single-dose intravenous and oral administration. Twelve healthy piglets received matrine at 8 mg/kg body weight via either the intravenous or oral route, and plasma concentrations were quantified using a validated UPLC–MS/MS method. Pharmacokinetic parameters were estimated by non-compartmental analysis. Compared with intravenous administration, oral dosing produced lower observed exposure based on and a lower peak plasma concentration, with and values of 418.94 ± 75.52 h·ng/mL and 66.24 ± 8.44 ng/mL, respectively, versus 558.01 ± 59.57 h·ng/mL and 224.64 ± 20.94 ng/mL after intravenous administration. Oral administration was associated with a of 2.49 ± 0.02 h and a longer apparent terminal half-life and mean residence time than intravenous dosing. These findings provide pharmacokinetic evidence to support future route selection, dosing-regimen design, and PK/PD-based dose optimization of matrine in pigs. - 15 June 2026
- Published by Wiley in Veterinary Record Case Reports
- Vol. 14 (3)
Complete response to toceranib phosphate treatment in a dog with an intranasal mast cell tumour
Intranasal mast cell tumours (MCTs) are rare in dogs and are diagnostically and therapeutically challenging. This case describes a 13‐year‐old spayed female Chinese Native Dog presenting with facial swelling and bilateral submandibular lymphadenopathy. Fine‐needle aspiration identified a round cell neoplasm with eosinophilic infiltration, and histopathology with toluidine blue staining confirmed intranasal MCT. The tumour was classified as T 1 N 1 M 0 and was most consistent with WHO stage IIa. Toceranib phosphate was administered orally at approximately 2.63 mg/kg per dose three times weekly, resulting in complete resolution of the facial mass within 7 days, accompanied by regression of lymphadenopathy and no recurrence during follow‐up. Mild, self‐limiting vomiting developed at week 4 and was managed with cimetidine. The dog died suddenly 89 days after treatment initiation from an undetermined cause without postmortem examination. This case highlights the potential of toceranib as a treatment option for intranasal MCTs in anatomically challenging locations and supports further clinical evaluation.
- 15 June 2026
- Published by Wiley in Veterinary Record Case Reports
- Vol. 14 (3)
Complete response to toceranib phosphate treatment in a dog with an intranasal mast cell tumour
Intranasal mast cell tumours (MCTs) are rare in dogs and are diagnostically and therapeutically challenging. This case describes a 13‐year‐old spayed female Chinese Native Dog presenting with facial swelling and bilateral submandibular lymphadenopathy. Fine‐needle aspiration identified a round cell neoplasm with eosinophilic infiltration, and histopathology with toluidine blue staining confirmed intranasal MCT. The tumour was classified as T 1 N 1 M 0 and was most consistent with WHO stage IIa. Toceranib phosphate was administered orally at approximately 2.63 mg/kg per dose three times weekly, resulting in complete resolution of the facial mass within 7 days, accompanied by regression of lymphadenopathy and no recurrence during follow‐up. Mild, self‐limiting vomiting developed at week 4 and was managed with cimetidine. The dog died suddenly 89 days after treatment initiation from an undetermined cause without postmortem examination. This case highlights the potential of toceranib as a treatment option for intranasal MCTs in anatomically challenging locations and supports further clinical evaluation.
- Open Access
- 12 June 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 578
Integrated Network Pharmacology and Cross-Species Analysis Suggest a Potential Role of AKT1/HIF1A Axis in Shuanghuanglian for Pneumonia–Myocarditis Comorbidity
Shuanghuanglian oral liquid (SHL) is widely used in companion animals and poultry, but its molecular mechanism in pneumonia–myocarditis comorbidity and heart–lung inflammatory crosstalk remains largely unclear. This computational study investigated the conserved AKT1/HIF1A-mediated immunoregulatory mechanism of SHL and its cross-species translational potential in veterinary medicine. Network pharmacology was integrated with GO, KEGG, and Reactome enrichment analyses, protein–protein interaction network construction, ADMET evaluation, cross-species sequence homology analysis (human, dog, cattle, and pig), molecular docking, and molecular dynamics simulation. A total of 61 active compounds, 251 putative targets, and 52 common targets associated with pneumonia and myocarditis were identified. These targets were mainly enriched in inflammation- and immune-related pathways, including TNF, IL-17, AGE–RAGE, and PPAR signaling. AKT1 and HIF1A showed high sequence conservation across species (85–98%). Key compounds exhibited favorable binding affinity to AKT1, and molecular dynamics simulation suggested the stability of the Baicalein–AKT1 complex. ADMET analysis suggested favorable pharmacokinetic properties and low predicted toxicity. These findings suggest that SHL may potentially alleviate pneumonia and myocarditis through modulation of the conserved AKT1/HIF1A axis and support its potential as a complementary therapeutic approach for managing heart–lung inflammatory diseases in multiple livestock species. This entirely computational study highlights promising mechanisms that should be further validated in vivo.
- 12 June 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 578
Open AccessIntegrated Network Pharmacology and Cross-Species Analysis Suggest a Potential Role of AKT1/HIF1A Axis in Shuanghuanglian for Pneumonia–Myocarditis Comorbidity
Shuanghuanglian oral liquid (SHL) is widely used in companion animals and poultry, but its molecular mechanism in pneumonia–myocarditis comorbidity and heart–lung inflammatory crosstalk remains largely unclear. This computational study investigated the conserved AKT1/HIF1A-mediated immunoregulatory mechanism of SHL and its cross-species translational potential in veterinary medicine. Network pharmacology was integrated with GO, KEGG, and Reactome enrichment analyses, protein–protein interaction network construction, ADMET evaluation, cross-species sequence homology analysis (human, dog, cattle, and pig), molecular docking, and molecular dynamics simulation. A total of 61 active compounds, 251 putative targets, and 52 common targets associated with pneumonia and myocarditis were identified. These targets were mainly enriched in inflammation- and immune-related pathways, including TNF, IL-17, AGE–RAGE, and PPAR signaling. AKT1 and HIF1A showed high sequence conservation across species (85–98%). Key compounds exhibited favorable binding affinity to AKT1, and molecular dynamics simulation suggested the stability of the Baicalein–AKT1 complex. ADMET analysis suggested favorable pharmacokinetic properties and low predicted toxicity. These findings suggest that SHL may potentially alleviate pneumonia and myocarditis through modulation of the conserved AKT1/HIF1A axis and support its potential as a complementary therapeutic approach for managing heart–lung inflammatory diseases in multiple livestock species. This entirely computational study highlights promising mechanisms that should be further validated in vivo.
- Open Access
- 4 June 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 555
Porcine Erythrocyte–PRRSV Interactions: Implications for Targeted Nanodrug Delivery
Objective: To establish a porcine complement receptor type 1-like (CR1-like)-mediated targeted anti-porcine reproductive and respiratory syndrome virus (PRRSV) nanodrug delivery system by investigating interactions between erythrocytes from Landrace piglets (both male and female), PRRSV, and anti-PRRSV nanodrugs. Methods: Optimal conditions for PRRSV sensitization with fresh porcine serum were determined. CR1-like-dependent immune adhesion of porcine erythrocytes to sensitized PRRSV was verified by immunofluorescence, electron microscopy, qPCR, and Western blot. The effect of this adhesion on PRRSV infection of porcine alveolar macrophages (PAMs) was studied using a flow chamber system. Mannose-modified matrine nanoliposomes (MMLNPs) were prepared, characterized, and evaluated for cytotoxicity, targeting ability, and in vitro antiviral activity. Results: PRRSV was optimally sensitized by incubation with fresh porcine serum at 37 °C for 2 h. Porcine erythrocytes specifically adhered to sensitized PRRSV via CR1-like, significantly promoting PRRSV infection of PAMs. Stable, uniform-sized MMLNPs showed no cytotoxicity, targeted PAMs via CR1-like, and exhibited superior antiviral activity to free matrine. Conclusions: CR1-like-mediated immune adhesion is a critical mechanism for PRRSV infection of PAMs. Harnessing this natural pathway enables efficient targeted delivery of matrine nanoliposomes to PAMs, providing a promising translational strategy for PRRSV control.
- 4 June 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 555
Open AccessPorcine Erythrocyte–PRRSV Interactions: Implications for Targeted Nanodrug Delivery
Objective: To establish a porcine complement receptor type 1-like (CR1-like)-mediated targeted anti-porcine reproductive and respiratory syndrome virus (PRRSV) nanodrug delivery system by investigating interactions between erythrocytes from Landrace piglets (both male and female), PRRSV, and anti-PRRSV nanodrugs. Methods: Optimal conditions for PRRSV sensitization with fresh porcine serum were determined. CR1-like-dependent immune adhesion of porcine erythrocytes to sensitized PRRSV was verified by immunofluorescence, electron microscopy, qPCR, and Western blot. The effect of this adhesion on PRRSV infection of porcine alveolar macrophages (PAMs) was studied using a flow chamber system. Mannose-modified matrine nanoliposomes (MMLNPs) were prepared, characterized, and evaluated for cytotoxicity, targeting ability, and in vitro antiviral activity. Results: PRRSV was optimally sensitized by incubation with fresh porcine serum at 37 °C for 2 h. Porcine erythrocytes specifically adhered to sensitized PRRSV via CR1-like, significantly promoting PRRSV infection of PAMs. Stable, uniform-sized MMLNPs showed no cytotoxicity, targeted PAMs via CR1-like, and exhibited superior antiviral activity to free matrine. Conclusions: CR1-like-mediated immune adhesion is a critical mechanism for PRRSV infection of PAMs. Harnessing this natural pathway enables efficient targeted delivery of matrine nanoliposomes to PAMs, providing a promising translational strategy for PRRSV control.
- Open Access
- 30 December 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 33
Structural and Functional Analysis of Porcine CR1-like Proteins in C4b-Mediated Immune Responses
The complement system is crucial for immune defense, linking innate and adaptive immunity. In the classical and lectin pathways, C4 is split into C4b, triggering opsonization, lysis, and the removal of pathogens and damaged cells. Dysregulated activation of C4 and other components of the classical pathway can lead to tissue damage and heightened inflammation, whereas appropriate regulation of C4b activity serves to mitigate excessive inflammation and prevent injury. ELISA analysis demonstrated C4 activation and cleavage during the co-incubation of PRRSV with fresh porcine serum. Immunoelectron microscopy revealed that porcine red blood cells could immunologically adhere to PRRSV, and C4b was involved in this adhesion process. BLAST (NCBI BLAST+ 2.14.1) analysis revealed that porcine CR1-like CCPs 1-3, CR1-like CCPs 12-14, and CR1-like CCPs 19-21 share high similarity with the CCP 1-3 region of human CR1, which mediates C4b binding. Yeast two-hybrid assays confirmed that all three CR1-like fragments bind C4b. To elucidate the interaction mechanism, homology models of C4b and CR1-like fragments were constructed, followed by molecular docking and dynamics simulations, identifying 18 key amino acids in porcine CR1-like involved in C4b binding. Surface plasmon resonance further validated the binding affinity of CR1-like CCPs 1-3, its mutant 118I, and C4b. These results enhance our understanding of complement regulation and provide a foundation for developing therapeutic strategies targeting complement-related diseases.
- 30 December 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 33
Open AccessStructural and Functional Analysis of Porcine CR1-like Proteins in C4b-Mediated Immune Responses
The complement system is crucial for immune defense, linking innate and adaptive immunity. In the classical and lectin pathways, C4 is split into C4b, triggering opsonization, lysis, and the removal of pathogens and damaged cells. Dysregulated activation of C4 and other components of the classical pathway can lead to tissue damage and heightened inflammation, whereas appropriate regulation of C4b activity serves to mitigate excessive inflammation and prevent injury. ELISA analysis demonstrated C4 activation and cleavage during the co-incubation of PRRSV with fresh porcine serum. Immunoelectron microscopy revealed that porcine red blood cells could immunologically adhere to PRRSV, and C4b was involved in this adhesion process. BLAST (NCBI BLAST+ 2.14.1) analysis revealed that porcine CR1-like CCPs 1-3, CR1-like CCPs 12-14, and CR1-like CCPs 19-21 share high similarity with the CCP 1-3 region of human CR1, which mediates C4b binding. Yeast two-hybrid assays confirmed that all three CR1-like fragments bind C4b. To elucidate the interaction mechanism, homology models of C4b and CR1-like fragments were constructed, followed by molecular docking and dynamics simulations, identifying 18 key amino acids in porcine CR1-like involved in C4b binding. Surface plasmon resonance further validated the binding affinity of CR1-like CCPs 1-3, its mutant 118I, and C4b. These results enhance our understanding of complement regulation and provide a foundation for developing therapeutic strategies targeting complement-related diseases.
- Open Access
- 24 June 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-10
Development of a colloidal gold immunochromatographic strip to detect equine infectious anemia virus
Equine infectious anemia virus (EIAV) poses a significant global threat to the equine industry, resulting in considerable economic losses and compromised horse health. Given the limited treatment options available, early detection and prevention strategies are essential to combat this viral infection. In this study, we introduce a novel colloidal gold immunochromatographic (ICLF) strip for the rapid and accurate detection of EIAV antibodies. The strip incorporates a unique fusion protein, p26-gp90, designed to enhance both the specificity and sensitivity of the detection method for EIAV antibodies. Through rigorous method validation, our strip has exhibited superior performance compared to existing detection methods. It demonstrates high sensitivity, improved specificity, and excellent stability, enabling reliable and long-term storage. Additionally, the strip allows for fast and precise analysis of clinical samples, making it an invaluable tool for the early detection and prevention of EIAV. The availability of such an accurate and efficient detection method will greatly enhance our ability to combat EIAV by enabling the early identification of infected horses and facilitating effective preventive measures. • Rapid and sensitive detection methods are essential for preventing EIAV infection. • A novel ICLF strip for EIAV antibodies was developed using p26-gp90 fusion protein. • The ICLF strip allows for on-site sensitive detection of EIAV in a short period.
- 24 June 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-10
Open AccessDevelopment of a colloidal gold immunochromatographic strip to detect equine infectious anemia virus
Equine infectious anemia virus (EIAV) poses a significant global threat to the equine industry, resulting in considerable economic losses and compromised horse health. Given the limited treatment options available, early detection and prevention strategies are essential to combat this viral infection. In this study, we introduce a novel colloidal gold immunochromatographic (ICLF) strip for the rapid and accurate detection of EIAV antibodies. The strip incorporates a unique fusion protein, p26-gp90, designed to enhance both the specificity and sensitivity of the detection method for EIAV antibodies. Through rigorous method validation, our strip has exhibited superior performance compared to existing detection methods. It demonstrates high sensitivity, improved specificity, and excellent stability, enabling reliable and long-term storage. Additionally, the strip allows for fast and precise analysis of clinical samples, making it an invaluable tool for the early detection and prevention of EIAV. The availability of such an accurate and efficient detection method will greatly enhance our ability to combat EIAV by enabling the early identification of infected horses and facilitating effective preventive measures. • Rapid and sensitive detection methods are essential for preventing EIAV infection. • A novel ICLF strip for EIAV antibodies was developed using p26-gp90 fusion protein. • The ICLF strip allows for on-site sensitive detection of EIAV in a short period.
- Open Access
- 22 May 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (6) , 509
Development of an Immunochromatographic Test with Recombinant MIC2-MIC3 Fusion Protein for Serological Detection of Toxoplasma gondii
Toxoplasma gondii is a globally significant zoonotic pathogen responsible for severe parasitic diseases in humans and animals. This study aimed to design, develop, and evaluate a novel immunochromatographic test (ICT) using a recombinant MIC2-MIC3 fusion protein (rMIC2-MIC3) for detecting specific antibodies against T. gondii. The ICT demonstrated exceptional sensitivity, capable of detecting T. gondii-specific antibodies in sera diluted up to 1:8. Specificity evaluation confirmed no cross-reactivity with antibodies against other parasites, such as Neospora caninum, Cryptosporidium suis, Eimeria tenella, and Sarcocystis tenella. Stability tests revealed the test strips maintained full functionality after 12 weeks of storage at 24 °C. The coincidence rate of the colloidal gold test strips prepared in this study with a commercial ELISA kit was 94.59%. Comparisons with advanced serodiagnostic tools, such as chimeric antigen-based ELISAs and recombinant protein diagnostics, further highlighted its robustness and applicability. These findings underscore the potential of the rMIC2-MIC3-based ICT as a reliable, economical, and accessible diagnostic tool for toxoplasmosis in veterinary and human medicine.
- 22 May 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (6) , 509
Open AccessDevelopment of an Immunochromatographic Test with Recombinant MIC2-MIC3 Fusion Protein for Serological Detection of Toxoplasma gondii
Toxoplasma gondii is a globally significant zoonotic pathogen responsible for severe parasitic diseases in humans and animals. This study aimed to design, develop, and evaluate a novel immunochromatographic test (ICT) using a recombinant MIC2-MIC3 fusion protein (rMIC2-MIC3) for detecting specific antibodies against T. gondii. The ICT demonstrated exceptional sensitivity, capable of detecting T. gondii-specific antibodies in sera diluted up to 1:8. Specificity evaluation confirmed no cross-reactivity with antibodies against other parasites, such as Neospora caninum, Cryptosporidium suis, Eimeria tenella, and Sarcocystis tenella. Stability tests revealed the test strips maintained full functionality after 12 weeks of storage at 24 °C. The coincidence rate of the colloidal gold test strips prepared in this study with a commercial ELISA kit was 94.59%. Comparisons with advanced serodiagnostic tools, such as chimeric antigen-based ELISAs and recombinant protein diagnostics, further highlighted its robustness and applicability. These findings underscore the potential of the rMIC2-MIC3-based ICT as a reliable, economical, and accessible diagnostic tool for toxoplasmosis in veterinary and human medicine.